According to data from Qizhidao, Sino-British Anocon (Ningxia) Biotechnology Co., Ltd. was established on August 18, 2014, with a registered capital of 80 million yuan and 38 insured persons. It is a company mainly engaged in pharmaceutical manufacturing. A national high-tech enterprise focusing on industry. The company has been awarded the qualifications and honors of "National High-tech Enterprise" and "National Science and Technology Small and Medium-sized Enterprises".

In terms of intellectual property rights, Sino-British Anocon (Ningxia) Biotechnology Co., Ltd. has 41 registered trademarks, 5 software copyrights, and 55 patent information. In addition, Sino-British Anocon (Ningxia) Biotechnology Co., Ltd. also directly controls one company.